GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CuraScientific Corp (OTCPK:CSTF) » Definitions » Pretax Margin %

CuraScientific (CuraScientific) Pretax Margin % : -2,485.22% (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is CuraScientific Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. CuraScientific's Pre-Tax Income for the three months ended in Sep. 2023 was $-5.72 Mil. CuraScientific's Revenue for the three months ended in Sep. 2023 was $0.23 Mil. Therefore, CuraScientific's pretax margin for the quarter that ended in Sep. 2023 was -2,485.22%.

The historical rank and industry rank for CuraScientific's Pretax Margin % or its related term are showing as below:

CSTF' s Pretax Margin % Range Over the Past 10 Years
Min: -15494.12   Med: -8106.67   Max: 5020.12
Current: 5020.12


CSTF's Pretax Margin % is ranked better than
99.71% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 4.15 vs CSTF: 5020.12

CuraScientific Pretax Margin % Historical Data

The historical data trend for CuraScientific's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CuraScientific Pretax Margin % Chart

CuraScientific Annual Data
Trend Dec20 Dec21 Dec22
Pretax Margin %
-8,106.67 -6,825.58 -15,494.12

CuraScientific Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 9,359.41 -2,485.22

Competitive Comparison of CuraScientific's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CuraScientific's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CuraScientific's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CuraScientific's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where CuraScientific's Pretax Margin % falls into.



CuraScientific Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

CuraScientific's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-5.268/0.034
=-15,494.12 %

CuraScientific's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-5.716/0.23
=-2,485.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CuraScientific  (OTCPK:CSTF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


CuraScientific Pretax Margin % Related Terms

Thank you for viewing the detailed overview of CuraScientific's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CuraScientific (CuraScientific) Business Description

Traded in Other Exchanges
N/A
Address
51544 Cesar Chavez Street, Suite No. 1J, Coachella, CA, USA, 92236
CuraScientific Corp manufactures commercial chemicals with a variety of commercial sterilization applications for agriculture, warehousing, hospitality, and medical facilities. The company's product, DiOx+, is a disinfectant sterilizer that kills harmful pathogens without exposing people or the environment to dangerous toxins.
Executives
Paul Quentin Goyette director 2205 LOCH WAY, EL DORADO HILLS CA 95762
William Joseph Reed director, officer: Chief Executive Officer 333 N UNIVERSITY AVE., #33, REDLANDS CA 92374
Johann Loewen director C/O METHES ENERGIES INTERNATIONAL LTD, 3651 LINDELL ROAD, SUITE D-272, LAS VEGAS NV 89103
Edouard Maurice Beaudette director 13480 N BLOOMFIELD ROAD, NEVADA CITY CA 95959
Justin Michael Gonzalez director, officer: Chief Executive Officer 15723 LAKE VERA PURDON RD., NEVADA CITY CA 95959
Eric Jason Watson director, officer: Chief Operating Officer 19553 BOWERS DRIVE, TOPANGA CA 90290

CuraScientific (CuraScientific) Headlines

From GuruFocus

Introducing Leaf of Faith

By Marketwired Marketwired 03-26-2019